Equity
€2.2m ▲ 32.4%
TIGMA paid out €2,784 in dividends. That is 1% of the 2025 profit.
TIGMA
Lifetime
5 annual accounts with figures on one time axispeak €818,797 (2025)
€818,797▲ 70.0%
peak €551,817 (2025)
€551,817▲ 68.1%
peak €2.2m (2025)
€2.2m▲ 32.4%
€112,488▲ 687%
Board1 name since 2021
1 director
Documentsfilings and deeds
21-01-202610 days before the deadline
2025abbreviated format
Gross margin from €481,624 to €818,797Result from €328,300 to €551,817Dividend €2,784Equity from €1.7m to €2.2mDebts from €14,286 to €112,488Cash from €1.2m to €1.8m
Key points
from the 2025 annual accountsResult
€551,817 ▲ 68.1%
The result rose in 2025 from €328,300 to €551,817.
Position in the sector
95.2%
Higher solvency than 93% of companies in human health. Sector median 59.4% · 2,807 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 6,780 companies had the same profile as TIGMA has now. Each dot stands for 17 companies, two years later.
96.7%
were still trading
2.7%
stopped another way
0.6%
went bankrupt
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,780 companies, not a prediction for TIGMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Demerger: TIMOTHY GHYS MEDISCHE ANALYSES splits off to TIGMA
Capital of €5,000, 100 shares · Appointment: (director) · General meeting of 25-05-2021 · Gazette deed
First establishment
Ruilare 126, Lochristi
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| TIGMA Lochristi | €2.4m | €818,797 | 95.2% | - |
| CTMED Manage | €1.9m | €807,221 | 46.7% | 0.7 |
| BASTEX Fléron | €2.0m | €975,609 | 59.5% | 1.8 |
| Medisch Huis Terhagen Rumst | €1.7m | €991,603 | 60.3% | - |
| MED ZENGIN Braine-l'Alleud | €2.3m | €858,629 | 30.4% | 3.2 |
| Praktijkhuis Korte Klaren Antwerp | €1.8m | €823,004 | 86.5% | 8.3 |
| IMMO 577 Schaerbeek | €1.6m | €637,017 | 37.3% | - |
These companies have the same main activity as TIGMA: general medical practice (NACE 86210). They are comparable in size and age: total assets between €1.6m and €2.3m, founded between 2018 and 2022.
Official details
Source: KBO- Status
- Active since 31-05-2021Normal situation
- Activity
- General medical practiceNACE 86210and 2 others
- Establishment unit
- 2.325.597.2699080 Lochristi, since 31-05-2021
- Financial year end
- 30 June
- Peppol
- Reachable
Annual accounts to 30-06-2025
- ≈ €1.6mestimated
- €2.4m▲ 37.9%
- Filing
- Filed on 21-01-2026, 10 days before the end of the filing period
Insights on TIGMA
TIGMA files the abbreviated format. That format states no turnover. The gross margin rose from €641,648 in 2021 to €818,797 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about TIGMA
- What is the company number of TIGMA?
- The company number of TIGMA is 0768.900.093. The VAT number is the same number with BE in front: BE 0768.900.093.
- Where is TIGMA based?
- The registered office is at Ruilare 126, 9080 Lochristi.Company details
- What does TIGMA do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of TIGMA?
- TIGMA is a private limited company (BV).
- When was TIGMA founded?
- TIGMA was founded on 31-05-2021.
- Is TIGMA still active?
- Yes, TIGMA is an active enterprise in the KBO register.
- What is the turnover of TIGMA?
- The turnover in financial year 2025 is ≈ €1.6m. This figure is estimated from the gross margin of €818,797 and 41 comparable companies (NACE 862). It probably lies between €1.1m and €2.5m.Financials
- Is TIGMA profitable?
- In financial year 2025, TIGMA made a profit of €551,817.
- Where can I find the annual accounts of TIGMA?
- TIGMA filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of TIGMA due?
- TIGMA must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.